000 00898 a2200241 4500
005 20250515223240.0
264 0 _c20110617
008 201106s 0 0 eng d
022 _a1177-5483
024 7 _a10.2147/opth.s8598
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGhazi, Nicola G
245 0 0 _aIs monthly retreatment with intravitreal bevacizumab (Avastin) necessary in neovascular age-related macular degeneration?
_h[electronic resource]
260 _bClinical ophthalmology (Auckland, N.Z.)
_cApr 2010
300 _a307-14 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aKirk, Tyler Q
700 1 _aKnape, Robert M
700 1 _aTiedeman, James S
700 1 _aConway, Brian P
773 0 _tClinical ophthalmology (Auckland, N.Z.)
_gvol. 4
_gp. 307-14
856 4 0 _uhttps://doi.org/10.2147/opth.s8598
_zAvailable from publisher's website
999 _c19818472
_d19818472